企業プロフィール
DexCom, Inc. 株価・ニュース・カタリスト
- ティッカー:
- DXCM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
88.76 USD (-1.10%)
終値
最終更新: 2026年8月17日
28.3B USD
時価総額
株価変動の要因
As of Aug 17, 2026, DXCM closed down 1.10% at $88.76. No new same-company headline was identified in the current news window.
企業概要
事業概要
DexCom is a leading medical technology company focused on continuous glucose monitoring for diabetes care. The company’s platform is built around connected sensors, recurring usage, and the expansion of CGM across broader patient populations.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, DexCom is a healthcare technology company with strong exposure to diabetes monitoring. It sits in device-driven chronic care rather than drug development.
ビジネスモデルの特徴
DexCom generates revenue through sensor sales, platform adoption, and recurring glucose-monitoring usage. Investors track user growth, reimbursement, product launches, and whether the company can keep extending CGM beyond its core base.
バイオ業界での位置付け
DexCom is not biotech proper, but it is one of the most important diabetes technology names in healthcare. It is more about device adoption and recurring use than binary clinical or FDA-drug events.
今後のカタリスト
- Dexcom’s watchlist is G7 adoption, international expansion, and sensor-cycle execution that supports recurring revenue. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。